Biomanufacturing Productivity Improvement Support Service
First written in FY2024. 5 of 9 entries say "Achieved", first in 2026-05-13. Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026AchievedAnnual report
「Orders for the bio-manufacturing support service have progressed favorably since its launch in July, enabling us to achieve revenue of ¥127,226 thousand, exceeding the annual revenue target.」
The biomanufacturing support service was launched in July, and ¥127.226 million in sales was recorded in the fiscal year ending June 2026, exceeding the full-year sales target. - FY2026-H1AdvancedAnnual report
「Orders for the biomanufacturing support service have remained strong since its launch in July, and we have already recorded more than half of our full-year sales target in revenue.」
The biomanufacturing support service was launched in July, bringing us to the stage where more than half of the full-year sales target had been recorded by the end of the interim period. - FY2025-H1RestatedAnnual report
「In research and development, we also focused on developing new services for highly sensitive comprehensive analysis and on research and development to support productivity improvements in “biomanufacturing.”」
Research and development related to the biomanufacturing productivity improvement support service continued, and concentrated investment was made in this field during the interim consolidated accounting period. - FY2024First statedAnnual report
「We will develop a productivity improvement support service for “biomanufacturing.” Because this requires more high-throughput metabolome analysis technologies and advanced metabolic simulation technologies, our Group is working to establish these technologies by leveraging the technologies, expertise and other capabilities it has developed to date, and plans to begin working with pilot customers within the fiscal year.」
Developing a new service using metabolome analysis and metabolic simulation to support improved yields and cost reductions in biomanufacturing, with work with pilot customers scheduled to begin within the fiscal year.